These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 12477430)
1. Do not underestimate the power of antibodies--lessons from adoptive transfer of antibodies against HIV. Ferrantelli F; Rasmussen RA; Hofmann-Lehmann R; Xu W; McClure HM; Ruprecht RM Vaccine; 2002 Dec; 20 Suppl 4():A61-5. PubMed ID: 12477430 [TBL] [Abstract][Full Text] [Related]
2. Passive immunization as tool to identify protective HIV-1 Env epitopes. Kramer VG; Siddappa NB; Ruprecht RM Curr HIV Res; 2007 Nov; 5(6):642-55. PubMed ID: 18045119 [TBL] [Abstract][Full Text] [Related]
3. Antibodies: can they protect against HIV infection? Mc Cann CM; Song RJ; Ruprecht RM Curr Drug Targets Infect Disord; 2005 Jun; 5(2):95-111. PubMed ID: 15975016 [TBL] [Abstract][Full Text] [Related]
4. Neutralizing antibodies against HIV -- back in the major leagues? Ferrantelli F; Ruprecht RM Curr Opin Immunol; 2002 Aug; 14(4):495-502. PubMed ID: 12088685 [TBL] [Abstract][Full Text] [Related]
5. Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine. Ferrantelli F; Kitabwalla M; Rasmussen RA; Cao C; Chou TC; Katinger H; Stiegler G; Cavacini LA; Bai Y; Cotropia J; Ugen KE; Ruprecht RM J Infect Dis; 2004 Jan; 189(1):71-4. PubMed ID: 14702155 [TBL] [Abstract][Full Text] [Related]
6. Antibody protection: passive immunization of neonates against oral AIDS virus challenge. Ruprecht RM; Ferrantelli F; Kitabwalla M; Xu W; McClure HM Vaccine; 2003 Jul; 21(24):3370-3. PubMed ID: 12850342 [TBL] [Abstract][Full Text] [Related]
7. Primary African HIV clade A and D isolates: effective cross-clade neutralization with a quadruple combination of human monoclonal antibodies raised against clade B. Kitabwalla M; Ferrantelli F; Wang T; Chalmers A; Katinger H; Stiegler G; Cavacini LA; Chou TC; Ruprecht RM AIDS Res Hum Retroviruses; 2003 Feb; 19(2):125-31. PubMed ID: 12639248 [TBL] [Abstract][Full Text] [Related]
8. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. Ferrantelli F; Rasmussen RA; Buckley KA; Li PL; Wang T; Montefiori DC; Katinger H; Stiegler G; Anderson DC; McClure HM; Ruprecht RM J Infect Dis; 2004 Jun; 189(12):2167-73. PubMed ID: 15181562 [TBL] [Abstract][Full Text] [Related]
9. The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region. Barnett SW; Lu S; Srivastava I; Cherpelis S; Gettie A; Blanchard J; Wang S; Mboudjeka I; Leung L; Lian Y; Fong A; Buckner C; Ly A; Hilt S; Ulmer J; Wild CT; Mascola JR; Stamatatos L J Virol; 2001 Jun; 75(12):5526-40. PubMed ID: 11356960 [TBL] [Abstract][Full Text] [Related]
10. Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa. Bures R; Morris L; Williamson C; Ramjee G; Deers M; Fiscus SA; Abdool-Karim S; Montefiori DC J Virol; 2002 Mar; 76(5):2233-44. PubMed ID: 11836401 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates. Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491 [TBL] [Abstract][Full Text] [Related]